World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Mylan Rejects Teva’s $40 Billion Takeover Offer
Keywords:
Tags: Pharmaceutical,
Mylan
06/15/2005
Grouped Articles
Mylan Proposes to Acquire Rival Perrigo for $28.9 Billion
Wall Street Journal 04/10/2015
Mylan Is Now Big Generics Player After Deal for Unit of Merck KGaA
Wall Street Journal 05/14/2007
Wall Street Journal 06/15/2005
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Generic Drug Makers Facing Squeeze on Revenue
New York Times 12/03/2012
Mylan management
06/15/2005
Grouped Articles
Mylan Proposes to Acquire Rival Perrigo for $28.9 Billion
Wall Street Journal 04/10/2015
Mylan Is Now Big Generics Player After Deal for Unit of Merck KGaA
Wall Street Journal 05/14/2007
Wall Street Journal 06/15/2005
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Mylan strategies
06/15/2005
Grouped Articles
Mylan Proposes to Acquire Rival Perrigo for $28.9 Billion
Wall Street Journal 04/10/2015
Mylan Is Now Big Generics Player After Deal for Unit of Merck KGaA
Wall Street Journal 05/14/2007
Wall Street Journal 06/15/2005
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Painted as EpiPen Villain, Mylan’s Chief Says She’s No Such Thing
The New York Times 08/26/2016
Teva acquisitions.
07/26/2005
Grouped Articles
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Teva Pharmaceuticals to Buy Allergan’s Generics Business
New York Times 07/27/2015
Teva to Acquire Ivax, Another Maker of Generic Drugs
New York Times 07/26/2005
Teva to Buy U.S. Generic Rival Barr for $7.46 Billion
Wall Street Journal 07/19/2008
Teva Deal Probe Gets Extension
Wall Street Journal 12/03/2008
Teva Pharmaceutical financial performance- 2011-2015
05/12/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/11/2013
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Wall Street Journal 05/12/2011
Teva Pharmaceutical's strategy
05/12/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/11/2013
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Threat of Generic Copycat Comes Back to Nip at Teva
Wall Street Journal 07/25/2011
Mylan acquisitions
06/15/2005
Grouped Articles
Mylan Proposes to Acquire Rival Perrigo for $28.9 Billion
Wall Street Journal 04/10/2015
Mylan Is Now Big Generics Player After Deal for Unit of Merck KGaA
Wall Street Journal 05/14/2007
Wall Street Journal 06/15/2005
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Mylan performance
06/15/2005
Grouped Articles
Mylan Proposes to Acquire Rival Perrigo for $28.9 Billion
Wall Street Journal 04/10/2015
Mylan Is Now Big Generics Player After Deal for Unit of Merck KGaA
Wall Street Journal 05/14/2007
Wall Street Journal 06/15/2005
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Mylan's proposed acquisition of Perrigo
06/15/2005
Grouped Articles
Mylan Proposes to Acquire Rival Perrigo for $28.9 Billion
Wall Street Journal 04/10/2015
Mylan Is Now Big Generics Player After Deal for Unit of Merck KGaA
Wall Street Journal 05/14/2007
Wall Street Journal 06/15/2005
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Pharmaceutical
05/21/2007
Grouped Articles
Wall Street Journal 10/11/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Teva Generic Approved; Court Blocks Launch
Wall Street Journal 05/21/2007
Wyeth Loses Bout in Fight on a Generic
New York Times 09/08/2007
Wyeth Hit by Generic Competition and Regulatory Setback
New York Times 12/25/2007
Teva Pharmaceutical management
05/12/2011
Grouped Articles
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Former Test-Tube Washer Built Generic-Drug Maker Teva
Wall Street Journal 11/23/2011
Teva Names a New Chief Executive
New York Times 01/02/2012
Wall Street Journal 05/08/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us